176 related articles for article (PubMed ID: 25068119)
1. Wilms' tumor blastemal stem cells dedifferentiate to propagate the tumor bulk.
Shukrun R; Pode-Shakked N; Pleniceanu O; Omer D; Vax E; Peer E; Pri-Chen S; Jacob J; Hu Q; Harari-Steinberg O; Huff V; Dekel B
Stem Cell Reports; 2014 Jul; 3(1):24-33. PubMed ID: 25068119
[TBL] [Abstract][Full Text] [Related]
2. The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets.
Pode-Shakked N; Shukrun R; Mark-Danieli M; Tsvetkov P; Bahar S; Pri-Chen S; Goldstein RS; Rom-Gross E; Mor Y; Fridman E; Meir K; Simon A; Magister M; Kaminski N; Goldmacher VS; Harari-Steinberg O; Dekel B
EMBO Mol Med; 2013 Jan; 5(1):18-37. PubMed ID: 23239665
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example.
Shukrun R; Pode Shakked N; Dekel B
Pediatr Nephrol; 2014 May; 29(5):815-23; quiz 821. PubMed ID: 23760992
[TBL] [Abstract][Full Text] [Related]
4. Blastemal NCAM
Raved D; Tokatly-Latzer I; Anafi L; Harari-Steinberg O; Barshack I; Dekel B; Pode-Shakked N
Pathol Res Pract; 2019 Aug; 215(8):152491. PubMed ID: 31202518
[TBL] [Abstract][Full Text] [Related]
5. Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population.
Pode-Shakked N; Metsuyanim S; Rom-Gross E; Mor Y; Fridman E; Goldstein I; Amariglio N; Rechavi G; Keshet G; Dekel B
J Cell Mol Med; 2009 Aug; 13(8B):1792-1808. PubMed ID: 20187302
[TBL] [Abstract][Full Text] [Related]
6. Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line.
Ueda K; Ogasawara S; Akiba J; Nakayama M; Todoroki K; Ueda K; Sanada S; Suekane S; Noguchi M; Matsuoka K; Yano H
PLoS One; 2013; 8(10):e75463. PubMed ID: 24116047
[TBL] [Abstract][Full Text] [Related]
7. SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms' tumor.
Murphy AJ; Pierce J; de Caestecker C; Taylor C; Anderson JR; Perantoni AO; de Caestecker MP; Lovvorn HN
J Pediatr Surg; 2012 Jun; 47(6):1239-49. PubMed ID: 22703800
[TBL] [Abstract][Full Text] [Related]
8. Wilms tumor--a renal stem cell malignancy?
Pode-Shakked N; Dekel B
Pediatr Nephrol; 2011 Sep; 26(9):1535-43. PubMed ID: 21499773
[TBL] [Abstract][Full Text] [Related]
9. Identification and Characterization of the Wilms Tumor Cancer Stem Cell.
Petrosyan A; Villani V; Aguiari P; Thornton ME; Wang Y; Rajewski A; Zhou S; Cravedi P; Grubbs BH; De Filippo RE; Sedrakyan S; Lemley KV; Csete M; Da Sacco S; Perin L
Adv Sci (Weinh); 2023 Jul; 10(20):e2206787. PubMed ID: 37114795
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of CITED1, SIX1, and CD56 protein expression for identification of blastemal elements in Wilms tumor.
Sehic D; Ciornei CD; Gisselsson D
Am J Clin Pathol; 2014 Jun; 141(6):828-33. PubMed ID: 24838327
[TBL] [Abstract][Full Text] [Related]
11. SIX1 protein expression selectively identifies blastemal elements in Wilms tumor.
Sehic D; Karlsson J; Sandstedt B; Gisselsson D
Pediatr Blood Cancer; 2012 Jul; 59(1):62-8. PubMed ID: 22180226
[TBL] [Abstract][Full Text] [Related]
12. Dissecting Stages of Human Kidney Development and Tumorigenesis with Surface Markers Affords Simple Prospective Purification of Nephron Stem Cells.
Pode-Shakked N; Pleniceanu O; Gershon R; Shukrun R; Kanter I; Bucris E; Pode-Shakked B; Tam G; Tam H; Caspi R; Pri-Chen S; Vax E; Katz G; Omer D; Harari-Steinberg O; Kalisky T; Dekel B
Sci Rep; 2016 Mar; 6():23562. PubMed ID: 27020553
[TBL] [Abstract][Full Text] [Related]
13. Stromal β-catenin activation impacts nephron progenitor differentiation in the developing kidney and may contribute to Wilms tumor.
Drake KA; Chaney CP; Das A; Roy P; Kwartler CS; Rakheja D; Carroll TJ
Development; 2020 Jul; 147(21):. PubMed ID: 32541007
[TBL] [Abstract][Full Text] [Related]
14. Metanephric adenoma, nephrogenic rests, and Wilms' tumor: a histologic and immunophenotypic comparison.
Muir TE; Cheville JC; Lager DJ
Am J Surg Pathol; 2001 Oct; 25(10):1290-6. PubMed ID: 11688464
[TBL] [Abstract][Full Text] [Related]
15. The in vitro growth, heterotransplantation, and immunohistochemical characterization of the blastemal component of Wilms' tumor.
Garvin AJ; Sullivan JL; Bennett DD; Stanley WS; Inabnett T; Sens DA
Am J Pathol; 1987 Nov; 129(2):353-63. PubMed ID: 2445211
[TBL] [Abstract][Full Text] [Related]
16. ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.
Charafe-Jauffret E; Ginestier C; Bertucci F; Cabaud O; Wicinski J; Finetti P; Josselin E; Adelaide J; Nguyen TT; Monville F; Jacquemier J; Thomassin-Piana J; Pinna G; Jalaguier A; Lambaudie E; Houvenaeghel G; Xerri L; Harel-Bellan A; Chaffanet M; Viens P; Birnbaum D
Cancer Res; 2013 Dec; 73(24):7290-300. PubMed ID: 24142344
[TBL] [Abstract][Full Text] [Related]
17. The stem and roots of Wilms' tumours.
Hohenstein P
EMBO Mol Med; 2013 Jan; 5(1):4-6. PubMed ID: 23239670
[No Abstract] [Full Text] [Related]
18. CITED1 confers stemness to Wilms tumor and enhances tumorigenic responses when enriched in the nucleus.
Murphy AJ; Pierce J; de Caestecker C; Ayers GD; Zhao A; Krebs JR; Saito-Diaz VK; Lee E; Perantoni AO; de Caestecker MP; Lovvorn HN
Oncotarget; 2014 Jan; 5(2):386-402. PubMed ID: 24481423
[TBL] [Abstract][Full Text] [Related]
19. Blastemal cells of nephroblastomatosis complex share an onco-developmental antigen with embryonic kidney and Wilms' tumor. An immunohistochemical study on polysialic acid distribution.
Roth J; Blaha I; Bitter-Suermann D; Heitz PU
Am J Pathol; 1988 Dec; 133(3):596-608. PubMed ID: 2849302
[TBL] [Abstract][Full Text] [Related]
20. CITED1 expression in Wilms' tumor and embryonic kidney.
Lovvorn HN; Westrup J; Opperman S; Boyle S; Shi G; Anderson J; Perlman EJ; Perantoni AO; Wills M; de Caestecker M
Neoplasia; 2007 Jul; 9(7):589-600. PubMed ID: 17710162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
